Company intelligence / Profile preview

Senderra

Dallas, Texas, United Statessenderrarx.com ↗

Ownership: Private
Employees: ~248
Development stage: Commercial

Overview

Largest independent full-service specialty pharmacy in the U.S. focused on supporting patients with complex and chronic conditions through specialty medications, expert clinical care, and comprehensive support services. Accredited by URAC and ACHC. Offers national coverage with advanced technology platforms to streamline prescription fulfillment and improve outcomes. No clinical trial results as it does not develop drugs.

Therapeutic areas: OtherOncologyImmunologyInfectious Diseases
Modalities: BiologicSmall molecule
Industry: Non-Academic Healthcare

Partnerships

Pharmaceutical manufacturers of HUMIRA biosimilars/adalimumab biosimilarsBroad partnerships with pharma companies for distribution of specialty drugs

Beyond the preview

Go deeper on Senderra.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Senderra.

Explore the full profile